MedPath
HSA Approval

AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION

SIN13977P

AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION

AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION

June 20, 2011

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

POWDER, FOR SUSPENSION

ORAL

Medical Information

J01FA10

azithromycin

Manufacturer Information

APOTHECA MARKETING PTE LTD

KERN PHARMA, S. L.

Active Ingredients

AZITHROMYCIN DIHYDRATE 209.62 mg/5 ml EQV AZITHROMYCIN ANHYDROUS

200 mg/5 ml

Azithromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION - HSA Approval | MedPath